Vascular smooth muscle cell-derived osteoprotegerin drives pulmonary arterial hypertension via AKT activation and is attenuated by monoclonal antibody therapy. [PDF]
Keles M +14 more
europepmc +1 more source
Paracrine action of bone morphogenetic protein 3 in pulmonary arterial hypertension. [PDF]
Halouani A +12 more
europepmc +1 more source
Apelin-13 attenuates hyperoxia-induced pulmonary arterial smooth muscle cell dysfunction via BMPR2/IL-6 modulation in pulmonary arterial hypertension. [PDF]
Pan F, Huang D, Mo L.
europepmc +1 more source
Role of Interleukin 34 in Pulmonary Vascular Remodeling Associated With Fibrosing Interstitial Lung Disease. [PDF]
Yokokawa T +20 more
europepmc +1 more source
Abstract Supplement HIV Glasgow 8–11 November 2026, Glasgow, UK/Virtual
Journal of the International AIDS Society, Volume 29, Issue S6, November 2026.
wiley +1 more source
RhoA Activation by Hypoxia in Pulmonary Arterial Smooth Muscle Cells Is Age and Site Specific [PDF]
Hypoxia induces vasoconstriction of pulmonary arteries through contraction of smooth muscle cells (SMCs). The GTPase RhoA regulates smooth muscle contractility and actin cytoskeletal remodeling through the Rho-associated kinase ( ROCK).
Anne Ridley +2 more
exaly +2 more sources
Activation of AMPK Inhibits Pulmonary Arterial Smooth Muscle Cells Proliferation
The aims of the present study were to examine the effect of AMPK activation on pulmonary arterial smooth muscle cells (PASMCs) proliferation and to address its potential mechanisms. ET-1 dose and time-dependently induced PASMCs proliferation, and this effect was suppressed by a selective AMPK activator metformin.
Lu Liu, Wei Feng, Guizuo Wang
exaly +3 more sources
Related searches:
Pulmonary arterial hypertension (PAH) is a progressive disease, characterized by a persistent elevation of pulmonary arterial pressure and pulmonary vascular remodelling. Recent studies implicated that long noncoding RNAs (lncRNAs) play important roles in the development of various diseases.
Shuang, Wang +8 more
openaire +2 more sources
FOXM1 promotes pulmonary artery smooth muscle cell expansion in pulmonary arterial hypertension
Journal of Molecular Medicine, 2017Pulmonary arterial hypertension (PAH) is a progressive vascular remodeling disease characterized by a persistent elevation of pulmonary artery pressure, leading to right heart failure and premature death. Exaggerated proliferation and resistance to apoptosis of pulmonary artery smooth muscle cells (PASMCs) is a key component of vascular remodeling ...
Alice Bourgeois +12 more
openaire +2 more sources
Mibefradil Suppresses the Proliferation of Pulmonary Artery Smooth Muscle Cells
Journal of Investigative Medicine, 2016Intracellular Ca 2+ levels play a critical role in the regulation of vasodilation and vasoconstriction by stimulating pulmonary artery smooth muscle cell (PASMC) proliferation, which is important in the pathogenesis of pulmonary arterial hypertension (PAH); however, L-type Ca
Hong-Hong, Li +4 more
openaire +2 more sources

